249 related articles for article (PubMed ID: 31053545)
1. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment.
Cano-Paniagua A; Amariles P; Angulo N; Restrepo-Garay M
Ann Hepatol; 2019; 18(3):501-507. PubMed ID: 31053545
[TBL] [Abstract][Full Text] [Related]
2. Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran.
Lewis JH; Larrey D; Olsson R; Lee WM; Frison L; Keisu M
Int J Clin Pharmacol Ther; 2008 Jul; 46(7):327-39. PubMed ID: 18793587
[TBL] [Abstract][Full Text] [Related]
3. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
4. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
5. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury in the Australian setting.
Sistanizad M; Peterson GM
J Clin Pharm Ther; 2013 Apr; 38(2):115-20. PubMed ID: 23350857
[TBL] [Abstract][Full Text] [Related]
7. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
8. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Teschke R; Schulze J; Eickhoff A; Danan G
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
[TBL] [Abstract][Full Text] [Related]
9. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review.
Wang R; Qi X; Yoshida EM; Méndez-Sánchez N; Teschke R; Sun M; Liu X; Su C; Deng J; Deng H; Hou F; Guo X
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):425-434. PubMed ID: 29323538
[TBL] [Abstract][Full Text] [Related]
11. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
Ghabril M; Gu J; Yoder L; Corbito L; Dakhoul L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00141. PubMed ID: 32251016
[TBL] [Abstract][Full Text] [Related]
12. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
[TBL] [Abstract][Full Text] [Related]
13. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
[TBL] [Abstract][Full Text] [Related]
14. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
15. A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.
Hwang SJ; Wu JC; Lee CN; Yen FS; Lu CL; Lin TP; Lee SD
J Gastroenterol Hepatol; 1997 Jan; 12(1):87-91. PubMed ID: 9076631
[TBL] [Abstract][Full Text] [Related]
16. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.
Bagheri H; Michel F; Lapeyre-Mestre M; Lagier E; Cambus JP; Valdiguié P; Montastruc JL
Br J Clin Pharmacol; 2000 Nov; 50(5):479-84. PubMed ID: 11069443
[TBL] [Abstract][Full Text] [Related]
17. Montelukast induced acute hepatocellular liver injury.
Harugeri A; Parthasarathi G; Sharma J; D'Souza GA; Ramesh M
J Postgrad Med; 2009; 55(2):141-2. PubMed ID: 19550064
[TBL] [Abstract][Full Text] [Related]
18. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.
Rochon J; Protiva P; Seeff LB; Fontana RJ; Liangpunsakul S; Watkins PB; Davern T; McHutchison JG;
Hepatology; 2008 Oct; 48(4):1175-83. PubMed ID: 18798340
[TBL] [Abstract][Full Text] [Related]
19. The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents.
Treeprasertsuk S; Huntrakul J; Ridtitid W; Kullavanijaya P; Björnsson ES
Aliment Pharmacol Ther; 2010 Jun; 31(11):1200-7. PubMed ID: 20222907
[TBL] [Abstract][Full Text] [Related]
20. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
